65. 原発性免疫不全症候群 Primary immunodeficiency Clinical trials / Disease details


臨床試験数 : 482 薬物数 : 661 - (DrugBank : 119) / 標的遺伝子数 : 90 - 標的パスウェイ数 : 211

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00065390
(ClinicalTrials.gov)
July 200321/7/2003Pyrimethamine to Treat Autoimmune Lymphoproliferative SyndromePilot (Phase I-II) Study of Pyrimethamine (Daraprim) for the Treatment of the Autoimmune Lymphoproliferative Syndrome (ALPS)Autoimmune Disease;Lymphatic Disease;Lymphoproliferative DisorderDrug: PyrimethamineNational Institute of Allergy and Infectious Diseases (NIAID)NULLCompletedN/AN/ABoth8Phase 1United States
2NCT00013689
(ClinicalTrials.gov)
March 200128/3/2001Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative SyndromePilot Study of Pyrimethamine and Sulfadoxine (Fansidar) for the Treatment of Individuals With the Autoimmune Lymphoproliferative Syndrome (ALPS)Autoimmune Disease;Lymphoproliferative DisorderDrug: Fansidar (pyrimethamine and sulfadoxine)National Institute of Allergy and Infectious Diseases (NIAID)NULLCompletedN/AN/ABoth8Phase 1United States